about
Prognostic value of changes in quality of life scores in prostate cancer.The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.Predicting survival in prostate cancer: the role of quality of life assessment.Time and PSA threshold model prognosticates long-term overall and disease-specific survival in prostate cancer patients as early as 3 months after external beam radiation therapy.A risk-adjusted definition of biochemical recurrence after radical prostatectomy.
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Endpoints in prostate cancer clinical trials.
@ast
Endpoints in prostate cancer clinical trials.
@en
Endpoints in prostate cancer clinical trials.
@nl
type
label
Endpoints in prostate cancer clinical trials.
@ast
Endpoints in prostate cancer clinical trials.
@en
Endpoints in prostate cancer clinical trials.
@nl
prefLabel
Endpoints in prostate cancer clinical trials.
@ast
Endpoints in prostate cancer clinical trials.
@en
Endpoints in prostate cancer clinical trials.
@nl
P1433
P1476
Endpoints in prostate cancer clinical trials.
@en
P2093
Oliver Sartor
P304
101-7; discussion 107-8
P356
10.1016/S0090-4295(02)01585-6
P407
P433
P577
2002-09-01T00:00:00Z